D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Badger Meter
BMI
$3.66B
| $249K | ﹤0.01% |
4,649
-106
| -2% | -$6.46K |
|
|
CVET
3477
DELISTED
Covetrus, Inc. Common Stock
CVET
| $248K | ﹤0.01% |
30,497
+2,696
| +10% | +$30.8K |
|
|
MNDT
3478
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $248K | ﹤0.01% |
23,400
-186,600
| -89% | -$2.68M |
|
|
PLAN
3479
CALL
DELISTED
Anaplan, Inc.
PLAN
| $248K | ﹤0.01% |
8,200
| – | – |
|
|
CNCE
3480
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $247K | ﹤0.01% |
27,932
-12,499
| -31% | -$123K |
|
3481
Tompkins Financial
TMP
$1.45B
| $246K | ﹤0.01% |
+3,431
| New | +$284K |
|
|
COHR
3482
PUT
DELISTED
Coherent Inc
COHR
| $245K | ﹤0.01% |
+2,300
| New | +$322K |
|
3483
Afya
AFYA
$1.27B
| $244K | ﹤0.01% |
12,788
-111
| -0.9% | -$2.75K |
|
3484
Boot Barn
BOOT
$4.55B
| $244K | ﹤0.01% |
+18,899
| New | +$603K |
|
|
ESGR
3485
DELISTED
Enstar Group
ESGR
| $244K | ﹤0.01% |
1,537
+33
| +2% | +$6.05K |
|
3486
Ameriprise Financial
AMP
$46.8B
| $243K | ﹤0.01% |
+2,368
| New | +$351K |
|
|
BCPC
3487
Balchem Corp
BCPC
$5.23B
| $243K | ﹤0.01% |
2,466
-11,395
| -82% | -$1.17M |
|
3488
First Citizens BancShares
FCNCA
$24.6B
| $242K | ﹤0.01% |
727
-6,528
| -90% | -$3.02M |
|
3489
Helios Technologies
HLIO
$2.64B
| $242K | ﹤0.01% |
6,387
-3,667
| -36% | -$156K |
|
3490
PUT
Puma Biotechnology
PBYI
$406M
| $239K | ﹤0.01% |
28,300
-60,000
| -68% | -$583K |
|
|
EVV
3491
Eaton Vance Limited Duration Income Fund
EVV
$1.06B
| $238K | ﹤0.01% |
+22,500
| New | +$279K |
|
3492
Rithm Capital
RITM
$5.09B
| $238K | ﹤0.01% |
47,530
-534,969
| -92% | -$7.75M |
|
3493
ResMed
RMD
$28.3B
| $238K | ﹤0.01% |
1,614
+200
| +14% | +$31.9K |
|
3494
Haverty Furniture Companies
HVT
$401M
| $237K | ﹤0.01% |
19,896
-16,748
| -46% | -$295K |
|
3495
Shenandoah Telecom
SHEN
$632M
| $237K | ﹤0.01% |
4,813
-14,896
| -76% | -$662K |
|
|
BRSP
3496
BrightSpire Capital
BRSP
$681M
| $233K | ﹤0.01% |
+59,226
| New | +$649K |
|
3497
Future Fuel
FF
$204M
| $233K | ﹤0.01% |
20,663
+3,428
| +20% | +$38.1K |
|
3498
MGP Ingredients
MGPI
$378M
| $233K | ﹤0.01% |
8,671
-141,476
| -94% | -$4.83M |
|
|
PHK
3499
PIMCO High Income Fund
PHK
$861M
| $233K | ﹤0.01% |
+47,500
| New | +$323K |
|
|
CLVS
3500
DELISTED
Clovis Oncology, Inc.
CLVS
| $233K | ﹤0.01% |
36,567
-389,964
| -91% | -$3.13M |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.